vs

Side-by-side financial comparison of Emerson Electric (EMR) and Omnicom Group (OMC). Click either name above to swap in a different company.

Omnicom Group is the larger business by last-quarter revenue ($6.2B vs $4.3B, roughly 1.4× Emerson Electric). Emerson Electric runs the higher net margin — 13.9% vs 6.7%, a 7.2% gap on every dollar of revenue. On growth, Emerson Electric posted the faster year-over-year revenue change (4.1% vs -16.2%). Over the past eight quarters, Omnicom Group's revenue compounded faster (27.3% CAGR vs -0.3%).

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

Omnicom Group Inc. is an American global media, marketing, and corporate communications holding company, headquartered in New York City.

EMR vs OMC — Head-to-Head

Bigger by revenue
OMC
OMC
1.4× larger
OMC
$6.2B
$4.3B
EMR
Growing faster (revenue YoY)
EMR
EMR
+20.3% gap
EMR
4.1%
-16.2%
OMC
Higher net margin
EMR
EMR
7.2% more per $
EMR
13.9%
6.7%
OMC
Faster 2-yr revenue CAGR
OMC
OMC
Annualised
OMC
27.3%
-0.3%
EMR

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
EMR
EMR
OMC
OMC
Revenue
$4.3B
$6.2B
Net Profit
$605.0M
$418.7M
Gross Margin
53.2%
Operating Margin
17.8%
10.4%
Net Margin
13.9%
6.7%
Revenue YoY
4.1%
-16.2%
Net Profit YoY
3.4%
436.9%
EPS (diluted)
$1.07
$1.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMR
EMR
OMC
OMC
Q1 26
$6.2B
Q4 25
$4.3B
$5.5B
Q3 25
$4.9B
$4.0B
Q2 25
$4.6B
$4.0B
Q1 25
$4.4B
$3.7B
Q4 24
$4.2B
$4.3B
Q3 24
$4.6B
$3.9B
Q2 24
$4.4B
$3.9B
Net Profit
EMR
EMR
OMC
OMC
Q1 26
$418.7M
Q4 25
$605.0M
$-941.1M
Q3 25
$637.0M
$341.3M
Q2 25
$586.0M
$257.6M
Q1 25
$485.0M
$287.7M
Q4 24
$585.0M
$448.0M
Q3 24
$996.0M
$385.9M
Q2 24
$329.0M
$328.1M
Gross Margin
EMR
EMR
OMC
OMC
Q1 26
Q4 25
53.2%
-10.6%
Q3 25
51.9%
18.7%
Q2 25
52.6%
16.6%
Q1 25
53.5%
17.1%
Q4 24
53.5%
19.8%
Q3 24
51.3%
19.6%
Q2 24
52.8%
17.7%
Operating Margin
EMR
EMR
OMC
OMC
Q1 26
10.4%
Q4 25
17.8%
-17.7%
Q3 25
16.4%
13.1%
Q2 25
16.1%
10.9%
Q1 25
14.2%
12.3%
Q4 24
18.6%
15.9%
Q3 24
14.7%
15.5%
Q2 24
10.4%
13.2%
Net Margin
EMR
EMR
OMC
OMC
Q1 26
6.7%
Q4 25
13.9%
-17.0%
Q3 25
13.1%
8.5%
Q2 25
12.9%
6.4%
Q1 25
10.9%
7.8%
Q4 24
14.0%
10.4%
Q3 24
21.6%
9.9%
Q2 24
7.5%
8.5%
EPS (diluted)
EMR
EMR
OMC
OMC
Q1 26
$1.35
Q4 25
$1.07
$-4.78
Q3 25
$1.12
$1.75
Q2 25
$1.04
$1.31
Q1 25
$0.86
$1.45
Q4 24
$1.02
$2.27
Q3 24
$1.74
$1.95
Q2 24
$0.57
$1.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMR
EMR
OMC
OMC
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$20.3B
Total Assets
$41.9B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Total Debt
EMR
EMR
OMC
OMC
Q1 26
Q4 25
$7.6B
$9.3B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
$6.1B
Q3 24
$7.7B
Q2 24
$7.1B
Stockholders' Equity
EMR
EMR
OMC
OMC
Q1 26
Q4 25
$20.3B
$12.0B
Q3 25
$20.3B
$4.6B
Q2 25
$19.9B
$4.5B
Q1 25
$19.2B
$4.4B
Q4 24
$20.5B
$4.2B
Q3 24
$21.6B
$4.0B
Q2 24
$20.8B
$3.6B
Total Assets
EMR
EMR
OMC
OMC
Q1 26
Q4 25
$41.9B
$54.4B
Q3 25
$42.0B
$28.8B
Q2 25
$42.5B
$28.8B
Q1 25
$42.0B
$28.1B
Q4 24
$42.6B
$29.6B
Q3 24
$44.2B
$28.8B
Q2 24
$45.6B
$27.3B
Debt / Equity
EMR
EMR
OMC
OMC
Q1 26
Q4 25
0.37×
0.77×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
1.45×
Q3 24
0.36×
Q2 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMR
EMR
OMC
OMC
Operating Cash FlowLast quarter
$699.0M
Free Cash FlowOCF − Capex
$602.0M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
1.16×
TTM Free Cash FlowTrailing 4 quarters
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMR
EMR
OMC
OMC
Q1 26
Q4 25
$699.0M
$3.0B
Q3 25
$3.1B
$477.5M
Q2 25
$1.1B
$210.1M
Q1 25
$241.0M
$-786.8M
Q4 24
$777.0M
$1.9B
Q3 24
$3.3B
$568.7M
Q2 24
$1.1B
$-141.7M
Free Cash Flow
EMR
EMR
OMC
OMC
Q1 26
Q4 25
$602.0M
$3.0B
Q3 25
$2.7B
$438.4M
Q2 25
$977.0M
$168.0M
Q1 25
$154.0M
$-816.3M
Q4 24
$694.0M
$1.9B
Q3 24
$2.9B
$537.4M
Q2 24
$998.0M
$-180.9M
FCF Margin
EMR
EMR
OMC
OMC
Q1 26
Q4 25
13.9%
54.2%
Q3 25
54.9%
10.9%
Q2 25
21.5%
4.2%
Q1 25
3.5%
-22.1%
Q4 24
16.6%
43.5%
Q3 24
63.1%
13.8%
Q2 24
22.8%
-4.7%
Capex Intensity
EMR
EMR
OMC
OMC
Q1 26
Q4 25
2.2%
0.7%
Q3 25
8.9%
1.0%
Q2 25
2.0%
1.0%
Q1 25
2.0%
0.8%
Q4 24
2.0%
1.1%
Q3 24
9.1%
0.8%
Q2 24
2.1%
1.0%
Cash Conversion
EMR
EMR
OMC
OMC
Q1 26
Q4 25
1.16×
Q3 25
4.86×
1.40×
Q2 25
1.83×
0.82×
Q1 25
0.50×
-2.73×
Q4 24
1.33×
4.30×
Q3 24
3.35×
1.47×
Q2 24
3.31×
-0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

OMC
OMC

Segment breakdown not available.

Related Comparisons